vimarsana.com

Latest Breaking News On - Noxopharm ltd - Page 8 : vimarsana.com

Noxopharm hails new Sofra™ drug inflammation results

Noxopharm Ltd (ASX:NOX, OTC:NOXOF) CEO Dr Gisela Mautner tells Proactive a new pre-clinical product candidate from its Sofra™ technology platform, known as.

Noxopharm Ltd reveals new Sofra™ drug reduces inflammation

Noxopharm Ltd has Sofra™ inflammation research presented at European Molecular Biology Organisation event; commercial opportunities await

The research underpinning Noxopharm Ltd (ASX:NOX, OTC:NOXOF)’s Sofra™ technology platform has been showcased by the Hudson Institute of Medical Research’s.

Noxopharm Ltd set for busy period ahead with strong news flow expected from drug pipeline

Deep Dive - Noxopharm Ltd

Noxopharm Ltd to prioritise Chroma™ and Sofra™ programs; Veyonda trials to disband

Noxopharm Ltd to prioritise Chroma™ and Sofra™ programs; Veyonda trials to disband
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.